Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

HUMAHUMA
Showing 8 of 19 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in HUMACYTE INC

CITADEL ADVISORS LLC holds 1.4M shares of HUMA (HUMACYTE INC), worth $1.1M as of 2026-Q2. This is a new position. HUMA represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$1.1M

Current Shares

1.4M

Total Value Change

+$293,308

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
1.4M
-
$1.1M0.0%$0.78
35
2026-Q1
Exited
0
-100.0%
$00.0%$1.07
0
2025-Q4
Increased
1.6M
+75.4%
$1.5M0.0%$1.01
39
2025-Q3
Increased
892,952
+42.9%
$1.6M0.0%$1.73
34
2025-Q2
Decreased
624,758
-78.5%
$1.3M0.0%$2.12
0
2025-Q1
Increased
2.9M
+1598.3%
$5M0.0%$1.96
43
2024-Q4
Increased
171,462
+12.0%
$865,8830.0%$5.09
28
2024-Q3
Increased
153,144
+248.8%
$833,1030.0%$5.58
40

Other major holders of HUMA: BlackRock, Inc., BlackRock Finance, Inc., VANGUARD GROUP INC, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used